
    
      One of the greatest impacts on maternal/infant health in the United States today is mother's
      who have opioid use disorder also known as OUD. This study will look at how in-utero
      buprenorphine also known as subutex, effects both mother/fetus in prenatal stages with MRI's,
      blood draws, and a series of assessments. After the neonate is born, there will be follow-up
      with that baby for up to 2 years with another neonatal MRI, blood draws and infant/child
      assessments. Planning to enroll 200 mothers who have opioid use disorder and 100 mothers with
      no previous opioid use.
    
  